FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jalal Ghali

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Living Beings

Co-author Network

Publications

TOP 3
Hammam D Zmily; Anas Alani; Jalal K Ghali
Evaluation of lixivaptan in euvolemic and hypervolemic hyponatremia and heart failure treatment.
Audrey H Wu; Peter E Carson; Wayne C Levy; Alan B Miller; Gerald W Neuberg; Christopher M O'Connor; Kathleen B Welch; Jalal K Ghali
Association between bilirubin and mode of death in severe systolic heart failure.
Jalal K Ghali; Ahmed I Shah
Defining hyponatraemia: a call for action.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jalal Ghali (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Hammam D Zmily; Anas Alani; Jalal K Ghali
Evaluation of lixivaptan in euvolemic and hypervolemic hyponatremia and heart failure treatment.
Expert opinion on drug metabolism & toxicology 2013;9(5):645-55.
2013: Audrey H Wu; Peter E Carson; Wayne C Levy; Alan B Miller; Gerald W Neuberg; Christopher M O'Connor; Kathleen B Welch; Jalal K Ghali
Association between bilirubin and mode of death in severe systolic heart failure.
The American journal of cardiology 2013;111(8):1192-7.
2012: Jalal K Ghali; Ahmed I Shah
Defining hyponatraemia: a call for action.
European journal of heart failure 2012;14(10):1085-6.
2012: Anne L Taylor; Manuel Worcel; Susan Ziesche; W Tad Archambault; Jay N Cohn; Jalal K Ghali; Michael L Sabolinski; S William Tam
Effect of fixed-dose combined isosorbide dinitrate/hydralazine in elderly patients in the African-American heart failure trial.
Journal of cardiac failure 2012;18(8):600-6.
2012: Jalal K Ghali; Cesare Orlandi; William T Abraham
The efficacy and safety of lixivaptan in outpatients with heart failure and volume overload: results of a multicentre, randomized, double-blind, placebo-controlled, parallel-group study.
European journal of heart failure 2012;14(6):642-51.
2012: Sandip K Zalawadiya; Luis Afonso; Sidakpal S Panaich; Vikas Veeranna; Jalal K Ghali
Gender and ethnic differences in red cell distribution width and its association with mortality among low risk healthy United state adults.
The American journal of cardiology 2012;109(11):1664-70.
2012: Jalal K Ghali
The next frontier of clinical trials: personalized medicine for devices.
Journal of the American College of Cardiology 2012;59(17):1519-20.
2011: Jalal K Ghali
More is less.
Archives of internal medicine 2011;171(20):1859.
2011: Amil M Shah; Sung Hee Shin; Hicham Skali; Jalal K Ghali; Chung-Lieh Hung; Lars Køber; John J V McMurray; Marc A Pfeffer; Jean L Rouleau; Eric J Velazquez; Anil Verma; Scott D Solomon
Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both.
American heart journal 2011;162(4):685-91.
2011: Jalal K Ghali
CABG in patients with left ventricular dysfunction.
The New England journal of medicine 2011;365(5):468; author reply 470-1.
2011: Jalal K Ghali
Is hyponatremia a marker or a mediator?
The American journal of medicine 2011;124(8):e23; author reply e25.
2011: Hammam D Zmily; Nazia S Khan; Suleiman Daifallah; Jalal K Ghali
The potential role for lixivaptan in heart failure and in hyponatremia.
Expert opinion on investigational drugs 2011;20(6):831-48.
2011: Sandip K Zalawadiya; Hammam Zmily; Jareer O Farah; Suleiman Daifallah; Omaima Ali; Jalal K Ghali
Red cell distribution width and mortality in predominantly African-American population with decompensated heart failure.
Journal of cardiac failure 2011;17(4):292-8.
2011: Jalal K Ghali; Barry M Massie; Douglas L Mann; Michael W Rich
Guidelines are merely guidelines.
Journal of cardiac failure 2011;17(3):208-9.
2011: Hammam D Zmily; Suleiman Daifallah; Jalal K Ghali
Tolvaptan, hyponatremia, and heart failure.
International journal of nephrology and renovascular disease 2011;4():57-71.
2011: Jalal K Ghali; Barry M Massie; Douglas L Mann; Michael W Rich
Heart failure guidelines, performance measures, and the practice of medicine: mind the gap.
Journal of cardiac failure 2011;17(1):90.e1-4.
2010: Jalal K Ghali; Barry M Massie; Douglas L Mann; Michael W Rich
Heart failure guidelines, performance measures, and the practice of medicine: mind the gap.
Journal of the American College of Cardiology 2010;56(25):2077-80.
2010: Kirkwood F Adams; Mandeep R Mehra; Ron M Oren; Christopher M O'Connor; Jun R Chiong; Jalal K Ghali; Daniel J Lenihan; Stephanie H Dunlap; J Herbert Patterson; Todd A Schwartz; G Michael Felker
Prospective evaluation of the association between cardiac troponin T and markers of disturbed erythropoiesis in patients with heart failure.
American heart journal 2010;160(6):1142-8.
2010: Jalal K Ghali; Barry M Massie; Douglas L Mann; Michael W Rich
Guidelines, performance measures, and the practice of medicine: mind the gap.
Journal of cardiac failure 2010;16(12):915-8.
2010: T Barry Levine; Thomas Giles; David Radzik; Jalal K Ghali
Effect of dronedarone on exercise capacity and cardiac function in patients with severe left ventricular dysfunction and compensated stable heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2010;24(5-6):449-58.
2010: Audrey H Wu; Jalal K Ghali; Gerald W Neuberg; Christopher M O'Connor; Peter E Carson; Wayne C Levy
Uric acid level and allopurinol use as risk markers of mortality and morbidity in systolic heart failure.
American heart journal 2010;160(5):928-33.
2010: Jalal K Ghali; Hammam D Zmily; Jareer O Farah; Suleiman Daifallah
Lixivaptan, a non-peptide vasopressin V2 receptor antagonist for the potential oral treatment of hyponatremia.
IDrugs : the investigational drugs journal 2010;13(11):782-92.
2010: Jalal K Ghali
Do advanced practice nurses or physician assistants outperform cardiologists?
The American journal of cardiology 2010;106(9):1368.
2010: Jalal K Ghali
Do heart failure trials need an end point committee?
American heart journal 2010;160(4):571-3.
2010: Jalal K Ghali
Unified definition of clinical trials end points.
American heart journal 2010;160(4):e33.
2010: Jalal K Ghali
Subjective versus objective classification of NYHA class IV.
Journal of cardiac failure 2010;16(8):707; author reply 707.
2010: Jalal K Ghali
The challenges of properly identifying the cause of heart failure hospitalization.
Archives of internal medicine 2010;170(14):1274-5; author reply 1275.
2010: Jalal K Ghali; S William Tam
The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists.
Journal of cardiac failure 2010;16(5):419-31.
2010: Sung-Hee Shin; Chung-Lieh Hung; Hajime Uno; Amira H Hassanein; Anil Verma; Mikhail Bourgoun; Lars Køber; Jalal K Ghali; Eric J Velazquez; Robert M Califf; Marc A Pfeffer; Scott D Solomon
Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction, heart failure, or both.
Circulation 2010;121(9):1096-103.
2010: Jalal K Ghali
Aldosterone antagonists in patients with heart failure.
JAMA : the journal of the American Medical Association 2010;303(9):833-4; author reply 834-5.
2010: Larry A Allen; G Michael Felker; Mandeep Mehra; Jun R Chiong; Stephanie H Dunlap; Jalal K Ghali; Daniel J Lenihan; Ron M Oren; Lynne E Wagoner; Todd A Schwartz; Kirkwood F Adams
Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure.
Journal of cardiac failure 2010;16(3):230-8.
2010: Phillip D. Levy; Deepa Nandyal; Robert D Welch; Jie Lena Sun; Karen Pieper; Jalal K Ghali; Gregg C Fonarow; Mihai Gheorghiade; Mihai Gheorgiade; Christopher M O'Connor
Does aspirin use adversely influence intermediate-term postdischarge outcomes for hospitalized patients who are treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers? Findings from Organized Program to Facilitate Life-Saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
American heart journal 2010;159(2):222-230.e2.
2009: Khaled Bachour; Hammam Zmily; Mohammad Kizilbash; Khaled Awad; Rayan Hourani; Hazem Hammad; Jack D Sobel; Jalal K Ghali; Donald P Levine; Luis Afonso
Valvular perforation in left-sided native valve infective endocarditis.
Clinical cardiology 2009;32(12):E55-62.
2009: Kirkwood F Adams; Ileana L Piña; Jalal K Ghali; Lynne E Wagoner; Stephanie H Dunlap; Todd A Schwartz; Wendy Gattis Stough; Mandeep Mehra; Gary Michael Felker; Jun R Chiong; J Herbert Patterson; John Kim; Javed Butler; Ron M Oren
Prospective evaluation of the association between hemoglobin concentration and quality of life in patients with heart failure.
American heart journal 2009;158(6):965-71.
2009: Peter Carson; S William Tam; Jalal K Ghali; W Tad Archambault; Anne Taylor; Jay N Cohn; Virginia M Braman; Manuel Worcel; Inder S Anand
Relationship of quality of life scores with baseline characteristics and outcomes in the African-American heart failure trial.
Journal of cardiac failure 2009;15(10):835-42.
2009: Marc Klapholz; William T Abraham; Jalal K Ghali; Piotr Ponikowski; Stefan D Anker; Beat Knusel; Yan Sun; Scott M Wasserman; Dirk J van Veldhuisen
The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure.
European journal of heart failure 2009;11(11):1071-7.
2009: Jalal K Ghali; Theodore L Schreiber
Physician certification and implantable cardioverter-defibrillators.
JAMA : the journal of the American Medical Association 2009;302(9):941; author reply 942-3.
2009: Jalal K Ghali; Bashar Hamad; Uma Yasothan; Peter Kirkpatrick
Tolvaptan.
Nature reviews. Drug discovery 2009;8(8):611-2.
2009: Jalal K Ghali
Surgical ventricular reconstruction.
The New England journal of medicine 2009;361(5):529; author reply 531-2.
2009: Jalal K Ghali; John Wikstrand; Dirk J van Veldhuisen; Björn Fagerberg; Sidney Goldstein; Ake Hjalmarson; Peter Johansson; John Kjekshus; Lis Ohlsson; Ola Samuelsson; Finn Waagstein; Hans Wedel
The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).
Journal of cardiac failure 2009;15(4):310-8.
2009: Kirkwood F Adams; J Herbert Patterson; John H Patterson; Ron M Oren; Mandeep Mehra; Christopher M O'Connor; Ileana L Piña; Alan B Miller; Jun R Chiong; Stephanie H Dunlap; William G Cotts; Gary M Felker; Douglas D Schocken; Todd A Schwartz; Jalal K Ghali
Prospective assessment of the occurrence of anemia in patients with heart failure: results from the Study of Anemia in a Heart Failure Population (STAMINA-HFP) Registry.
American heart journal 2009;157(5):926-32.
2009: Dennis M McNamara; S William Tam; Michael L Sabolinski; Page Tobelmann; Karen Janosko; Lakshmi Venkitachalam; Elizabeth Ofili; Clyde W Yancy; Arthur M Feldman; Jalal K Ghali; Anne L Taylor; Jay N Cohn; Manuel Worcel
Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trial.
Journal of cardiac failure 2009;15(3):191-8.
2009: Jalal K Ghali
Irbesartan for heart failure with preserved ejection fraction.
The New England journal of medicine 2009;360(12):1257; author reply 1258-9.
2009: Jalal K Ghali
Anemia and heart failure.
Current opinion in cardiology 2009;24(2):172-8.
2009: Inder S Anand; Peter Carson; Elizabeth Galle; Rui Song; John Boehmer; Jalal K Ghali; Brian Jaski; JoAnn Lindenfeld; Christopher O'Connor; Jonathan S Steinberg; Jill Leigh; Patrick Yong; Michael R Kosorok; Arthur M Feldman; David DeMets; Michael R Bristow
Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial.
Circulation 2009;119(7):969-77.
2009: Jalal K Ghali; Jareer O Farah; Suleiman Daifallah; Hassan A Zabalawi; Hammam D Zmily
Conivaptan and its role in the treatment of hyponatremia.
Drug design, development and therapy 2009;3():253-68.
2009: Alessandra Meris; Maria Amigoni; Hajime Uno; Jens jakob Thune; Anil Verma; Lars Køber; Mikhail Bourgoun; John J McMurray; Eric J Velazquez; Aldo P Maggioni; Jalal K Ghali; J Malcolm O Arnold; Steven Zelenkofske; Marc A Pfeffer; Scott D Solomon
Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study.
European heart journal 2009;30(1):56-65.
2008: Jalal K Ghali; S William Tam; Michael L Sabolinski; Anne L Taylor; JoAnn Lindenfeld; Jay N Cohn; Manuel Worcel
Exploring the potential synergistic action of spironolactone on nitric oxide-enhancing therapy: insights from the African-American Heart Failure Trial.
Journal of cardiac failure 2008;14(9):718-23.
2008: Anil Verma; Alessandra Meris; Hicham Skali; Jalal K Ghali; J Malcolm O Arnold; Mikhail Bourgoun; Eric J Velazquez; John J V McMurray; Lars Kober; Marc A Pfeffer; Robert M Califf; Scott D Solomon
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study.
JACC. Cardiovascular imaging 2008;1(5):582-91.
2008: Haroon A Faraz; Syed F Zafar; Jalal K Ghali
Anemia and the potential role of erythropoiesis-stimulating agents in heart failure.
Current heart failure reports 2008;5(2):83-90.
2008: Jalal K Ghali; JoAnn Lindenfeld
Sex differences in response to chronic heart failure therapies.
Expert review of cardiovascular therapy 2008;6(4):555-65.
2008: Nagesh S Anavekar; Hicham Skali; Mikhail Bourgoun; Jalal K Ghali; Lars Kober; Aldo P Maggioni; john mcmurray; Eric J Velazquez; Robert M Califf; Marc A Pfeffer; Scott D Solomon
Usefulness of right ventricular fractional area change to predict death, heart failure, and stroke following myocardial infarction (from the VALIANT ECHO Study).
The American journal of cardiology 2008;101(5):607-12.
2008: Teresa De Marco; Eugene E Wolfel; Arthur M Feldman; Brian D Lowes; Michael B Higginbotham; Jalal K Ghali; Lynne Wagoner; Philip C Kirlin; Jerry D Kennett; Satish Goel; Leslie A Saxon; John Boehmer; David Mann; Elizabeth Galle; Fred Ecklund; Patrick Yong; Michael R Bristow
Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
Journal of cardiac failure 2008;14(1):9-18.
2008: Jalal K Ghali; Peter Vietas Vaitkevicius
Fluid removal: are we any wiser?
Journal of cardiac failure 2008;14(1):6-8.
2008: Jalal K Ghali; Inder S Anand; William T Abraham; Gregg C Fonarow; Barry Greenberg; Henry Krum; Barrie Massie; Scott M Wasserman; Marie-Louise Trotman; Yan Sun; Beat Knusel; Paul Armstrong
Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia.
Circulation 2008;117(4):526-35.
2008: Jalal K Ghali
Mechanisms, risks, and new treatment options for hyponatremia.
Cardiology 2008;111(3):147-57.
2007: Jalal K Ghali; John Boehmer; Arthur M Feldman; Leslie A Saxon; Teresa DeMarco; Peter Carson; Patrick Yong; Elizabeth G Galle; Jill Leigh; Fred L Ecklund; Michael R Bristow
Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure.
Journal of cardiac failure 2007;13(9):769-73.
2007: Anil Verma; Nagesh S Anavekar; Alessandra Meris; Jens jakob Thune; J Malcolm O Arnold; Jalal K Ghali; Eric J Velazquez; john mcmurray; Marc A Pfeffer; Scott D Solomon
The relationship between renal function and cardiac structure, function, and prognosis after myocardial infarction: the VALIANT Echo Study.
Journal of the American College of Cardiology 2007;50(13):1238-45.
2007: Clyde W Yancy; Jalal K Ghali; Virginia M Braman; Michael L Sabolinski; Manuel Worcel; W Tad Archambault; Joseph A Franciosa
Evidence for the continued safety and tolerability of fixed-dose isosorbide dinitrate/hydralazine in patients with chronic heart failure (the extension to African-American Heart Failure Trial).
The American journal of cardiology 2007;100(4):684-9.
2007: Wilson S Colucci; Theodore J Kolias; Kirkwood F Adams; William F Armstrong; Jalal K Ghali; Stephen S Gottlieb; Barry Greenberg; Michael Klibaner; Marrick L Kukin; Jennifer E Sugg
Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
Circulation 2007;116(1):49-56.
2007: Jalal K Ghali; Michael V Orlov; Mohsen Araghi-Niknam; Lou Sherfesee; Douglas A Hettrick
The influence of symptoms and device detected atrial tachyarrhythmias on medical management: insights from A-HIRATE.
Pacing and clinical electrophysiology : PACE 2007;30(7):850-7.
2007: William Insull; Jalal K Ghali; David R Hassman; Joseph W Y As; Sanjay K Gandhi; Elinor Miller
Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial.
Mayo Clinic proceedings. Mayo Clinic 2007;82(5):543-50.
2007: Jalal K Ghali
Hydralazine and nitrates: beyond race and ethnicity.
Journal of cardiac failure 2007;13(3):238.
2007: Jalal K Ghali
Hyponatraemia in heart failure: a call for redefinition.
European heart journal 2007;28(8):920-1.
2007: Michael V Orlov; Jalal K Ghali; Mohsen Araghi-Niknam; Lou Sherfesee; Diane Sahr; Douglas A Hettrick
Asymptomatic atrial fibrillation in pacemaker recipients: incidence, progression, and determinants based on the atrial high rate trial.
Pacing and clinical electrophysiology : PACE 2007;30(3):404-11.
2007: Maria Amigoni; Alessandra Meris; Jens jakob Thune; Deepa Mangalat; Hicham Skali; Mikhail Bourgoun; J Wayne Warnica; Stale Barvik; J Malcolm O Arnold; Eric J Velazquez; Frans Van de Werf; Jalal K Ghali; john mcmurray; Lars Køber; Marc A Pfeffer; Scott D Solomon
Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: prognostic significance and relation to ventricular size and function.
European heart journal 2007;28(3):326-33.
2007: Jalal K Ghali; William B Smith; Guillermo Torre Amione; William Haynos; Barry K Rayburn; Antonino Amato; Dan Zhang; Doug Cowart; Giovanni Valentini; Paolo Carminati; Mihai Gheorghiade
A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic function.
The American journal of cardiology 2007;99(2A):47A-56A.
2007: JoAnn Lindenfeld; Arthur M Feldman; Leslie A Saxon; John Boehmer; Peter Carson; Jalal K Ghali; Inder S Anand; Steve Singh; Jonathan S Steinberg; Brian E Jaski; Teresa DeMarco; David Mann; Patrick Yong; Elizabeth Galle; Fred Ecklund; Michael R Bristow
Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
Circulation 2007;115(2):204-12.
2007: Jalal K Ghali; S William Tam; Keith C Ferdinand; JoAnn Lindenfeld; Michael L Sabolinski; Anne L Taylor; Manuel Worcel; Charles L Curry; Jay N Cohn
Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2007;7(5):373-80.
2007: Farhan Ali; Muhammad A. Raufi; Barbara Washington; Jalal K Ghali
Conivaptan: a dual vasopressin receptor v1a/v2 antagonist [corrected].
Cardiovascular drug reviews 2007;25(3):261-79.
2007: Farhan Ali; Maya E Guglin; Peter Vietas Vaitkevicius; Jalal K Ghali
Therapeutic potential of vasopressin receptor antagonists.
Drugs 2007;67(6):847-58.
2006: Jens jakob Thune; Lars Køber; Marc A Pfeffer; Hicham Skali; Nagesh S Anavekar; Mikhail Bourgoun; Jalal K Ghali; J Malcolm O Arnold; Eric J Velazquez; Scott D Solomon
Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic study.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2006;19(12):1462-5.
2006: Jalal K Ghali
There is still hope for multifaceted intervention in heart failure.
American heart journal 2006;152(4):e43; author reply e45.
2006: Jalal K Ghali; Michael J Koren; James R Taylor; Esther Brooks-Asplund; Kaisheng Fan; Walker A Long; Neila Smith
Efficacy and safety of oral conivaptan: a V1A/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia.
The Journal of clinical endocrinology and metabolism 2006;91(6):2145-52.
2006: Rodger A Liddle; Philip P Toskes; Jay Horrow; Jalal K Ghali; Abraham H Dachman; David Stong
Lack of trophic pancreatic effects in humans with long-term administration of ximelagatran.
Pancreas 2006;32(2):205-10.
2006: Marie Galvao; Jill Kalman; Teresa DeMarco; Gregg C Fonarow; Catherine Galvin; Jalal K Ghali; Robert Moskowitz
Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Journal of cardiac failure 2006;12(2):100-7.
2005: Peter Carson; Inder S Anand; Christopher O'Connor; Brian E Jaski; Jonathan Steinberg; Amy Lwin; JoAnn Lindenfeld; Jalal K Ghali; Jalil Ghali; Jodi H Barnet; Arthur M Feldman; Michael R Bristow
Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial.
Journal of the American College of Cardiology 2005;46(12):2329-34.
2005: Derek C Angus; Walter Linde-Zwirble; S William Tam; Jalal K Ghali; Michael L Sabolinski; Victor G Villagra; Wolfgang C Winkelmayer; Manuel Worcel
Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure.
Circulation 2005;112(24):3745-53.
2005: Henry Krum; Steven Joseph Haas; Eric Eichhorn; Jalal K Ghali; Edward Gilbert; Philippe Lechat; Milton Packer; Ellen B Roecker; Patricia Verkenne; Hans Wedel; John Wikstrand
Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.
European heart journal 2005;26(20):2154-8.
2005: Scott D Solomon; Hicham Skali; Mikhail Bourgoun; James Fang; Jalal K Ghali; Michel Martelet; Dariusz Wojciechowski; Baiba Ansmite; Janis Skards; Toivo Laks; David Henry; Milton Packer; Marc A Pfeffer
Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study.
American heart journal 2005;150(2):257-62.
2005: Jalal K Ghali
Beta-blockers in selected heart failure populations.
Current heart failure reports 2005;2(2):100-5.
2005: Scott D Solomon; Hicham Skali; Nagesh S Anavekar; Mikhail Bourgoun; Stale Barvik; Jalal K Ghali; J Wayne Warnica; Margarita Khrakovskaya; J Malcolm O Arnold; Yuri Schwartz; Eric J Velazquez; Robert M Califf; John V McMurray; Marc A Pfeffer
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
Circulation 2005;111(25):3411-9.
2005: Jalal K Ghali
Influence of pretreatment systolic blood pressure on benefit from carvedilol in severe chronic heart failure patients.
Journal of the American College of Cardiology 2005;45(5):809; author reply 809-10.
2005: Prakash C Deedwania; Thomas D Giles; Michael Klibaner; Jalal K Ghali; Johan Herlitz; Per Hildebrandt; John Kjekshus; Jindrich Spinar; Jiri Vitovec; Hilary Stanbrook; John Wikstrand
Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
American heart journal 2005;149(1):159-67.
2004: Jalal K Ghali; Peter H J M Dunselman; Finn Waagstein; Sidney Goldstein; Stephen S Gottlieb; Prakash C Deedwania; John Wikstrand
Consistency of the beneficial effect of metoprolol succinate extended release across a wide range dose of angiotensin-converting enzyme inhibitors and digitalis.
Journal of cardiac failure 2004;10(6):452-9.
2004: Jalal K Ghali
Cerebroprotection mediated by angiotensin II.
Journal of the American College of Cardiology 2004;44(10):2097; author reply 2097-8.
2004: Prakash C Deedwania; Stephen S Gottlieb; Jalal K Ghali; Finn Waagstein; John C M Wikstrand
Efficacy, safety and tolerability of beta-adrenergic blockade with metoprolol CR/XL in elderly patients with heart failure.
European heart journal 2004;25(15):1300-9.
2004: Jalal K Ghali
Diuretic use, progressive heart failure, and death in patients in SOLVD.
Journal of the American College of Cardiology 2004;43(9):1723; author reply 1723.
2004: Mihai Gheorghiade; Wendy A Gattis; Christopher M O'Connor; Kirkwood F Adams; Uri Elkayam; Alejandro Barbagelata; Jalal K Ghali; Raymond L Benza; Frank A McGrew; Marc Klapholz; John Ouyang; Cesare Orlandi
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2004;291(16):1963-71.
2004: Jalal K Ghali
Sex-related differences in heart failure and beta-blockers.
Heart failure reviews 2004;9(2):149-59.
2003: Jalal K Ghali; Heidi Krause-Steinrauf; Kirkwood F Adams; Steven S Khan; Yves D Rosenberg; Clyde W Yancy; James B Young; Steven Goldman; Mary Ann Peberdy; JoAnn Lindenfeld
Gender differences in advanced heart failure: insights from the BEST study.
Journal of the American College of Cardiology 2003;42(12):2128-34.
2003: Jalal K Ghali
Effect of valsartan on hospitalization in Val-HeFT.
Journal of cardiac failure 2003;9(5):424; author reply 424.
2003: András Jánosi; Jalal K Ghali; Johan Herlitz; István Czuriga; Michael Klibaner; John Wikstrand; Ake Hjalmarson
Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF.
American heart journal 2003;146(4):721-8.
2003: JoAnn Lindenfeld; Jalal K Ghali; Heidi Krause-Steinrauf; Steven Khan; Kirkwood F Adams; Steven Goldman; Mary Ann Peberdy; Clyde W Yancy; Surai Thaneemit; Rhonda L Larsen; James Young; Brian D Lowes; Yves D Rosenberg
Hormone replacement therapy is associated with improved survival in women with advanced heart failure.
Journal of the American College of Cardiology 2003;42(7):1238-45.
2003: Michael J Domanski; Heidi Krause-Steinrauf; Prakash Deedwania; dean follmann; Jalal K Ghali; Edward Gilbert; Steven M Haffner; Richard Katz; JoAnn Lindenfeld; Brian D Lowes; Wade Martin; Frank A McGrew; Michael R Bristow
The effect of diabetes on outcomes of patients with advanced heart failure in the BEST trial.
Journal of the American College of Cardiology 2003;42(5):914-22.
2003: John Wikstrand; Hans Wedel; Jalal K Ghali; Prakash Deedwania; Björn Fagerberg; Sidney Goldstein; Stephen S Gottlieb; Ake Hjalmarson; John Kjekshus; Finn Waagstein
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Cardiac electrophysiology review 2003;7(3):264-75.
2003: H C Wijeysundera; Mark S Hansen; Eric Stanton; A S Cropp; C Hall; N S Dhalla; Jalal K Ghali; Jean-Lucien Rouleau
Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine.
American heart journal 2003;146(2):291-7.
2003: Jalal K Ghali
Decompensated heart failure revisited.
The American journal of medicine 2003;114(8):695-6.
2003: Jalal K Ghali
Heart failure with preserved systolic function after myocardial infarction: a growing burden?
American heart journal 2003;145(4):575-8.
2002: Jalal K Ghali
Anemia and poor prognosis in advanced heart failure.
Journal of the American College of Cardiology 2002;40(12):2204; author reply 2204.
2002: Jalal K Ghali
Race, ethnicity, and heart failure.
Journal of cardiac failure 2002;8(6):387-9.
2002: Andrew J Burger; Darlene P Horton; Thierry H LeJemtel; Jalal K Ghali; Guillermo Torre; George Dennish; Michael Koren; Jay Dinerman; Marc Silver; Mei L Cheng; Uri Elkayam
Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
American heart journal 2002;144(6):1102-8.
2002: John Wikstrand; Jalal K Ghali; Sydney Goldstein
Consistency of ss-blocker effect across various subgroups with heart failure: insights from the MERIT-HF trial.
Postgraduate medicine 2002;112(5 Suppl Unanswered):16-23.
2002: Jalal K Ghali; Ileana L Piña; Stephen S Gottlieb; Prakash C Deedwania; John C Wikstrand
Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Circulation 2002;105(13):1585-91.
2002: Marc A Silver; Darlene P Horton; Jalal K Ghali; Uri Elkayam
Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure.
Journal of the American College of Cardiology 2002;39(5):798-803.
2001: Y Liao; Jalal K Ghali; L Berzins; R S Cooper
Coronary angiographic findings in African-American and white patients from a single institution.
Journal of the National Medical Association 2001;93(12):465-74.
2001: Jalal K Ghali
Fallacy of the mean.
Journal of cardiac failure 2001;7(4):365-6.
2001: James E Udelson; W B Smith; Grady H. Hendrix; C A Painchaud; M Ghazzi; I Thomas; Jalal K Ghali; P Selaru; F Chanoine; Milton L Pressler; Marvin A Konstam
Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure.
Circulation 2001;104(20):2417-23.
2001: Jalal K Ghali
Sex differences in the prognosis of congestive heart failure.
Circulation 2001;104(15):E81.
2001: Michael R Zile; William H Gaasch; J D Carroll; Marc D Feldman; Gerard P Aurigemma; G L Schaer; Jalal K Ghali; P R Liebson
Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?
Circulation 2001;104(7):779-82.
2001: Andrew J Burger; Uri Elkayam; M T Neibaur; H Haught; Jalal K Ghali; Darlene P Horton; D Aronson
Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy.
The American journal of cardiology 2001;88(1):35-9.
2001: Jalal K Ghali
A clinician's perspective on clinical trials.
Journal of cardiac failure 2001;7(1):1-3.
2000: Jalal K Ghali
The COHERE Registry: hype or hope?
Journal of cardiac failure 2000;6(3):272-5.
2000: T Barry Levine; PJ Bernink; Avi Caspi; Uri Elkayam; E M Geltman; B Greenberg; W J McKenna; Jalal K Ghali; T D Giles; Alon Marmor; Leonardo Reisin; S Ammon; E Lindberg
Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial.
Circulation 2000;101(7):758-64.
1999: Jalal K Ghali
Contemporary issues in heart failure.
American heart journal 1999;138(1 Pt 1):5-8.
1998: Jalal K Ghali
Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
The American journal of cardiology 1998;82(5):703.
1998: Jalal K Ghali; L Mosely; F Abreo; Kenneth Abreo
A 65-year-old woman with heart failure.
The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 1998;150(8):350-4.
1998: Jalal K Ghali; Y Liao; R S Cooper
Influence of left ventricular geometric patterns on prognosis in patients with or without coronary artery disease.
Journal of the American College of Cardiology 1998;31(7):1635-40.
1998: Jalal K Ghali; L Mosley; J Danzell; B Eaves
Heart failure in women.
The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 1998;150(2):85-91.
1997: Jalal K Ghali; T Giles; M Gonzales; R Horswell; S Kumar; A Lejuene; G F Livaudais; I C Sarkar
Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 1997;149(12):474-84.
1997: Jalal K Ghali
Carvedilol and dose-related improvements in left ventricular function.
Circulation 1997;96(8):2743-4.
1997: Emile R Mohler; L C Sorensen; Jalal K Ghali; D D Schocken; P W Willis; J A Bowers; Anne B Cropp; Milton L Pressler
Role of cytokines in the mechanism of action of amlodipine: the PRAISE Heart Failure Trial. Prospective Randomized Amlodipine Survival Evaluation.
Journal of the American College of Cardiology 1997;30(1):35-41.
1997: Y Liao; Richard S Cooper; Ramon Durazo-Arvizu; George Mensah; Jalal K Ghali
Prediction of mortality risk by different methods of indexation for left ventricular mass.
Journal of the American College of Cardiology 1997;29(3):641-7.
1996: C Liendo; Jalal K Ghali; S W Graves
A new interference in some digoxin assays: anti-murine heterophilic antibodies.
Clinical pharmacology and therapeutics 1996;60(5):593-8.
1996: Milton Packer; Christopher M O'Connor; Jalal K Ghali; Milton L Pressler; P E Carson; R N Belkin; Alan B Miller; G W Neuberg; D Frid; J H Wertheimer; Anne B Cropp; D L DeMets
Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.
The New England journal of medicine 1996;335(15):1107-14.
1996: Jalal K Ghali
SWORD trial of d-sotalol.
Lancet 1996;348(9030):827.
1996: D M Shindler; John B Kostis; S Yusuf; Miguel A Quinones; Bertram Pitt; D Stewart; T Pinkett; Jalal K Ghali; A C Wilson
Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry.
The American journal of cardiology 1996;77(11):1017-20.
1996: Jalal K Ghali
Inotropic therapy for the failing myocardium.
Clinical cardiology 1996;19(3):162.
1995: Jalal K Ghali
Carvedilol therapy in heart failure--I.
Journal of the American College of Cardiology 1995;26(5):1399; author reply 1400-1.
1995: Jalal K Ghali
Effect of nifedipine on pulmonary hemodynamics.
American heart journal 1995;129(6):1227-8.
1995: Y Liao; Richard S Cooper; D L McGee; George Mensah; Jalal K Ghali
The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults.
JAMA : the journal of the American Medical Association 1995;273(20):1592-7.
1995: Jalal K Ghali
Ischemic heart failure.
The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 1995;147(5):202-7.
1994: Jalal K Ghali
Heart failure and noncompliance in the elderly.
Archives of internal medicine 1994;154(18):2109-10.
1993: Claude R Benedict; D H Weiner; D E Johnstone; M G Bourassa; Jalal K Ghali; John M Nicklas; P Kirlin; B Greenberg; Miguel A Quinones; S Yusuf
Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the Studies of Left Ventricular Dysfunction (SOLVD) Registry. The SOLVD Investigators.
Journal of the American College of Cardiology 1993;22(4 Suppl A):146A-153A.
1993: M G Bourassa; O Gurné; Shrikant I Bangdiwala; Jalal K Ghali; J B Young; M Rousseau; D E Johnstone; S Yusuf
Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators.
Journal of the American College of Cardiology 1993;22(4 Suppl A):14A-19A.
1993: Jalal K Ghali
Heart failure versus CHF.
American heart journal 1993;125(6):1815.
1993: Y Liao; Richard S Cooper; Jalal K Ghali; D Lansky; G Cao; J Lee
Sex differences in the impact of coexistent diabetes on survival in patients with coronary heart disease.
Diabetes care 1993;16(5):708-13.
1993: Jalal K Ghali
Coronary heart failure and left ventricular diastolic dysfunction.
Annals of internal medicine 1993;118(7):569.
1993: Jalal K Ghali; R S Cooper; I Kowatly; Y Liao
Delay between onset of chest pain and arrival to the coronary care unit among minority and disadvantaged patients.
Journal of the National Medical Association 1993;85(3):180-4.
1992: Jalal K Ghali; Y Liao; R S Cooper
Ventricular hypertrophy, diuretic drugs and arrhythmias.
Journal of the American College of Cardiology 1992;20(6):1443-4.
1992: Jalal K Ghali; Y Liao; B Simmons; A Castaner; G Cao; R S Cooper
The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease.
Annals of internal medicine 1992;117(10):831-6.
1992: Y Liao; Richard S Cooper; Jalal K Ghali; A Szocka
Survival rates with coronary artery disease for black women compared with black men.
JAMA : the journal of the American Medical Association 1992;268(14):1867-71.
1992: Jalal K Ghali; Y Liao; Richard S Cooper; G Cao
Changes in pulmonary hemodynamics with aging in a predominantly hypertensive population.
The American journal of cardiology 1992;70(3):367-70.
1992: Shrikant I Bangdiwala; D H Weiner; M G Bourassa; G C Friesinger; Jalal K Ghali; S Yusuf
Studies of Left Ventricular Dysfunction (SOLVD) Registry: rationale, design, methods and description of baseline characteristics.
The American journal of cardiology 1992;70(3):347-53.
1992: Jalal K Ghali; S Kadakia; A Bhatt; R Cooper; Y Liao
Survival of heart failure patients with preserved versus impaired systolic function: the prognostic implication of blood pressure.
American heart journal 1992;123(4 Pt 1):993-7.
1992: Jalal K Ghali; R S Cooper; E Ford
Hospitalization for heart failure.
Archives of internal medicine 1992;152(3):649, 655.
1992: Jalal K Ghali
Electrocardiographic left ventricular hypertrophy: what do we measure?
Ethnicity & disease 1992;2(1):7-9.
1991: W B Hood; M Youngblood; Jalal K Ghali; M Reid; W J Rogers; D Howe; K K Teo; T H LeJemtel
Initial blood pressure response to enalapril in hospitalized patients (Studies of Left Ventricular Dysfunction [SOLVD]).
The American journal of cardiology 1991;68(15):1465-8.
1991: Jalal K Ghali; S Kadakia; R S Cooper; Y L Liao
Bedside diagnosis of preserved versus impaired left ventricular systolic function in heart failure.
The American journal of cardiology 1991;67(11):1002-6.
1991: Jalal K Ghali; S Kadakia; R S Cooper; Y L Liao
Impact of left ventricular hypertrophy on ventricular arrhythmias in the absence of coronary artery disease.
Journal of the American College of Cardiology 1991;17(6):1277-82.
1991: R S Cooper; Jalal K Ghali
Coronary heart disease: black-white differences.
Cardiovascular clinics 1991;21(3):205-25.
1991: Jalal K Ghali
Should cardiovascular diseases be a health priority for developing countries? A brief overview of the mortality data.
Ethnicity & disease 1991;1(3):295-9.
1991: R Cooper; Jalal K Ghali; B E Simmons; A Castaner
Elevated pulmonary artery pressure. An independent predictor of mortality.
Chest 1991;99(1):112-20.
1990: David M Mirvis; J Insel; M J Boland; M P Cinquegrani; Jalal K Ghali; S A Rubin; J Shanes; J DeSilva; J J Whalen
Chronic therapy for congestive heart failure with benazepril HCl, a new angiotensin converting enzyme inhibitor.
The American journal of the medical sciences 1990;300(6):354-60.
1990: Jalal K Ghali; R Cooper; E Ford
Trends in hospitalization rates for heart failure in the United States, 1973-1986. Evidence for increasing population prevalence.
Archives of internal medicine 1990;150(4):769-73.
1990: R S Cooper; B E Simmons; A Castaner; V Santhanam; Jalal K Ghali; M Mar
Left ventricular hypertrophy is associated with worse survival independent of ventricular function and number of coronary arteries severely narrowed.
The American journal of cardiology 1990;65(7):441-5.
1988: J G Shanes; C Wolfkiel; Jalal K Ghali; B J Dierenfeldt; George T Kondos; Jerry L Bauman
Acute hemodynamic effects of pindolol and propranolol in patients with dilated cardiomyopathy: relevance of intrinsic sympathomimetic activity.
American heart journal 1988;116(5 Pt 1):1268-75.
1988: Jalal K Ghali; S Kadakia; R Cooper; J Ferlinz
Precipitating factors leading to decompensation of heart failure. Traits among urban blacks.
Archives of internal medicine 1988;148(9):2013-6.
1988: Roberto M Lang; K M Borow; A Neumann; J D Carroll; Lynn Weinert; Michael B. Murphy; Jalal K Ghali; S I Rajfer
Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride.
The American journal of cardiology 1988;62(5):46C-52C.
1987: Jalal K Ghali; J G Shanes
A review of dilated cardiomyopathy.
Comprehensive therapy 1987;13(8):46-56.
1987: B E Simmons; A Castaner; V Santhanam; Jalal K Ghali; Norman A Silverman; D M Goldfaden; S Levitsky; R Cooper; J Ferlinz
Outcome of coronary artery bypass grafting in black persons.
The American journal of cardiology 1987;59(6):547-51.
1987: J G Shanes; Jalal K Ghali; M E Billingham; V J Ferrans; J J Fenoglio; W D Edwards; C C Tsai; J E Saffitz; J Isner; S Furner
Interobserver variability in the pathologic interpretation of endomyocardial biopsy results.
Circulation 1987;75(2):401-5.
1985: R Cooper; C Sempos; Jalal K Ghali; J Ferlinz
High-density lipoprotein cholesterol and angiographic coronary artery disease in black patients.
American heart journal 1985;110(5):1006-11.